Health Professional Radio - Podcast

Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences® discusses MI Exome™ a next-generation sequencing-based assay analyzing the whole exome of 22,000 DNA genes. This new assay will be offered as part of the Caris Molecular Intelligence® suite of comprehensive profiling services that are designed to detect and characterize the molecular features of cancer to guide more precise individualized treatment decisions for patients.